The expression levels of 5-LOX, FLAP mRNA in non-stimulated conditions, and in stimulated conditions in mast cells from AD patients, were examined for correlation with the SCORAD, a widely accepted tool for evaluating disease severity of AD patients, using the Spearman correlation test. The gene discussed is ALOX5; the disease is Alzheimer disease.